Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
227M
-
Number of holders
-
90
-
Total 13F shares, excl. options
-
62M
-
Shares change
-
-15.7M
-
Total reported value, excl. options
-
$74.4M
-
Value change
-
-$19.2M
-
Put/Call ratio
-
4.67
-
Number of buys
-
28
-
Number of sells
-
-65
-
Price
-
$1.20
Significant Holders of Gossamer Bio, Inc. - Common Stock (GOSS) as of Q2 2023
123 filings reported holding GOSS - Gossamer Bio, Inc. - Common Stock as of Q2 2023.
Gossamer Bio, Inc. - Common Stock (GOSS) has 90 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 62M shares
of 227M outstanding shares and own 27.28% of the company stock.
Largest 10 shareholders include HHLR ADVISORS, LTD. (4.97M shares), MILLENNIUM MANAGEMENT LLC (4.21M shares), Octagon Capital Advisors LP (3.96M shares), VANGUARD GROUP INC (3.58M shares), NEA Management Company, LLC (3.47M shares), Palo Alto Investors LP (3.47M shares), Opaleye Management Inc. (3.37M shares), Boxer Capital, LLC (3.34M shares), ACADIAN ASSET MANAGEMENT LLC (3.07M shares), and Artal Group S.A. (3.03M shares).
This table shows the top 90 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.